Chromadex Corp Stock
Your prediction
Chromadex Corp Stock
Chromadex Corp shows a slight decrease today, losing -€0.020 (-0.680%) compared to yesterday.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | -0.680% | 5.036% | 0.000% | -61.830% | -46.909% | 88.387% | -60.000% |
| Intellia Therapeutics Inc | 0.110% | -1.907% | -38.918% | -6.728% | 18.627% | -75.168% | -92.254% |
| Cardio3 Biosciences S.A. | -4.330% | 3.125% | 15.500% | -35.655% | 71.111% | -50.746% | -93.135% |
| Polynovo Ltd | 0.000% | 0.000% | -6.154% | -25.496% | -28.235% | -47.527% | -64.638% |
Comments
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat